Epstein-Barr Virus Defense Elevated with Monovaccine Innovation
February 9, 2024 ⚊ 1 Min read ⚊ Views 36 ⚊ BLOG
Epstein-Barr virus (EBV) is a common human virus that infects over 90% of adults worldwide. While EBV usually only causes a mild illness known as infectious mononucleosis or \”mono\”, it can also lead to several cancers in a small subset of individuals. For decades, researchers have tried to develop a vaccine against EBV but with limited success. A new type of EBV vaccine called a \”monovaccine\” shows promise and could help prevent EBV-driven cancers in the future.
Tags: Size Share Market Forecast Analysis
